HF
IBIO icon

HRT Financial’s iBio IBIO Stock Holding History

HRT Financial’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34,157
Closed -$28K – 3545
2025
Q3 		$28K Buy
+34,157
New +$26.2K ﹤0.01% 2668
2023
Q4 		– Sell
-3,181
Closed -$19K – 2658
2023
Q3 		$19K Buy
+3,181
New +$27.5K ﹤0.01% 2077
2023
Q1 		– Sell
-601
Closed -$5K – 2785
2022
Q4 		$5K Buy
601
+531
+759% +$18K ﹤0.01% 2270
2022
Q3 		$6K Sell
70
-219
-76% -$30.1K ﹤0.01% 2573
2022
Q2 		$38K Buy
+289
New +$43.4K ﹤0.01% 2538
2021
Q4 		– Sell
-22
Closed -$11K – 3579
2021
Q3 		$11K Buy
+22
New +$13.7K ﹤0.01% 3185

Other funds holding IBIO

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

HRT Financial's IBIO Position: Q4 2025 in Review

HRT Financial sold out of iBio (IBIO) in Q4 2025, closing a stake of 34,157 shares — an estimated $28K sold.

HRT Financial first reported a position in IBIO in Q3 2021 and held it in 6 quarters. The position peaked at $38K in Q2 2022. 50 funds tracked by Wall St. Rank hold IBIO as of Q4 2025.

  • HRT Financial reported no remaining iBio position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 34,157 iBio shares in Q4 2025, an estimated $28K.
  • HRT Financial first reported a position in iBio in Q3 2021 and held it in 6 quarters.
  • HRT Financial's iBio position peaked at $38K in Q2 2022.
  • 50 funds tracked by Wall St. Rank held iBio as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.